As of 2025-06-30, the EV/EBITDA ratio of Fulgent Genetics Inc (FLGT) is -11.35. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FLGT's latest enterprise value is 534.83 mil USD. FLGT's TTM EBITDA according to its financial statements is -47.11 mil USD. Dividing these 2 quantities gives us the above FLGT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 12.8x | 10.8x |
| Forward P/E multiples | 9.4x - 11.4x | 9.9x |
| Fair Price | (13.18) - (15.50) | (13.91) |
| Upside | -167.0% - -178.8% | -170.7% |
| Date | EV/EBITDA |
| 2025-06-26 | -11.30 |
| 2025-06-25 | -11.28 |
| 2025-06-24 | -11.25 |
| 2025-06-23 | -11.13 |
| 2025-06-20 | -11.26 |
| 2025-06-18 | -11.75 |
| 2025-06-17 | -11.73 |
| 2025-06-16 | -12.17 |
| 2025-06-13 | -12.00 |
| 2025-06-12 | -12.20 |
| 2025-06-11 | -12.67 |
| 2025-06-10 | -12.71 |
| 2025-06-09 | -12.73 |
| 2025-06-06 | -12.48 |
| 2025-06-05 | -12.09 |
| 2025-06-04 | -12.39 |
| 2025-06-03 | -12.32 |
| 2025-06-02 | -11.99 |
| 2025-05-30 | -12.02 |
| 2025-05-29 | -11.95 |
| 2025-05-28 | -11.91 |
| 2025-05-27 | -11.68 |
| 2025-05-23 | -11.76 |
| 2025-05-22 | -11.90 |
| 2025-05-21 | -11.74 |
| 2025-05-20 | -12.35 |
| 2025-05-19 | -12.35 |
| 2025-05-16 | -11.79 |
| 2025-05-15 | -11.59 |
| 2025-05-14 | -11.34 |
| 2025-05-13 | -11.75 |
| 2025-05-12 | -11.64 |
| 2025-05-09 | -11.37 |
| 2025-05-08 | -10.63 |
| 2025-05-07 | -10.69 |
| 2025-05-06 | -10.80 |
| 2025-05-05 | -11.27 |
| 2025-05-02 | -11.91 |
| 2025-05-01 | -9.78 |
| 2025-04-30 | -9.85 |
| 2025-04-29 | -10.35 |
| 2025-04-28 | -10.61 |
| 2025-04-25 | -10.84 |
| 2025-04-24 | -10.94 |
| 2025-04-23 | -10.85 |
| 2025-04-22 | -10.56 |
| 2025-04-21 | -10.22 |
| 2025-04-17 | -10.18 |
| 2025-04-16 | -10.47 |
| 2025-04-15 | -10.96 |